Menu
  • About Currax
    • Our Purpose and Values
    • Leadership
    • Press Releases
    • Corporate & Business Development
  • Products
    • Branded Products
      • CONTRAVE®
      • ONZETRA® Xsail®
      • SILENOR®
      • TREXIMET®
    • Generic Products
    • Report an Adverse Event
  • Responsibility
    • Currax Compliance Program and Annual Declaration
    • Currax Code of Business Conduct and Ethics
  • Careers
    • Benefits
    • EEO Statement
    • Search Jobs
    • Disclaimer/Warning
  • Contact Us
Currax Pharmaceuticals Delivers Strong Operational and Financial Performance Eight Months into Operations
Press Releases
February 27, 2020

Currax Pharmaceuticals Delivers Strong Operational and Financial Performance Eight Months into Operations

Read more
September 27, 2019

Currax™ Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.

Read more
September 26, 2019

Currax™ Pharmaceuticals LLC Announces First Acquisition: Acquires North American Rights to ONZETRA® Xsail®

Read more
May 1, 2019

Currax™ Holdings USA LLC Announces Launch and Close of Acquisition

Read more

© 2020 Currax Pharmaceuticals LLC. All rights reserved. This information is intended only for residents of the United States.

  • Terms of Use
  • Privacy Policy
  • Accessibility
  • Sitemap